ArrestAD communication

2017:

  • Participation to a congress with poster session (1)

-ADPD (13th International Conference on ADPD) 29 March -2 April 2017, Vienna, Austria. Differentially expressed plasma MicroRNAs in MCI-AD and AD. K. Laskowska-Kaszub, U. Wojda (NENCKI).

  • Participation to a conference (4)

– Envie de savoir, UPEC, Créteil, France. March 24th, 2017. AD: open mind for research. Ms. A. Maiza (UPEC).

– A*STAR Institute of Medical Biology, Singapore, July 2017. The matrix: the key to homeostasis, development and pathology. Prof. DG. Fernig (UoL).

– Invited lecture, 8th Annual World Congress of NeuroTalk-2017: New Technologies, New Ideas and New Future, Barcelona, Spain 22 – 24 May 2017. Circulating MicroRNAs in Blood as Biomarkers of Early Alzheimer’s disease. Prof. U. Wojda (NENCKI).

– Invited chair – organization of symposium ‘Novel biomarkers for early diagnosis of Alzheimer’s disease’ at 13th International Congress of Polish Neuroscience Society Warsaw,  29 August 2017 (~ 200 participants) (NENCKI).

– Congress of the British Society of Matrix Biology. April 3rd, 2017, Oxford, UK. Heparan sulfates as molecular chaperons in tau pathology. D. Papy-Garcia invited as pleanary speaker (UPEC).

– 13th International Congress of the Polish Neuroscience Society. 28th August 2017, Warsaw, Poland. Heparan sulfate sulfotransferases in Alzheimer’s disease. D. Papy-Garcia is invited pleanary speaker (UPEC).

– Innovation Match. May 31th, 2017, Mexico City, Mexico. Complex sugars in Fundamental Sciences and applications in biomedicine. D. Papy-Garcia was invited speaker (UPEC).

  • Participation to workshop (3)

-Workshop on Opportunities on Health, Mental Health and Neurosciences in H2020. Organized by Research Council – Spain. November 7th, 2017. Prof. L. Giménez-Llort (UAB).

– PCN FET – Rappel Rencontres FET Open 2018 – February 1st, 2018. Paris, France Prof. Papy-Garcia and Dr. Le Douaron (UPEC).

– Invited lecture, Workshop ‘From gene to phenotype – advances in molecular biology and biomedicine’ organized by Medical University of Warsaw, Poland. 13 – 15 March 2017. Alzheimer’s disease: development of novel models, biomarkers and therapies. Prof. U. Wojda (NENCKI).

  • Communication campaign (TV, other) (2)

– Magazine-program of the TV CyL7: El CIC de Salamanca investiga sobre el diagnóstico precoz del Alzheimer: February 7th, 2017. Prof. De Las Rivas (FICUS).

– Café scientifique – workshop on “Alzheimer’s disease – development of therapy and diagnostics” for a general audience at the Copernicus Science Center in Warsaw February 4th 2017. Prof. Urszula Wojda (NENCKI).

 

2018:

  • Participation to a congress with poster session (11: 9 Europe/2 international)

– GDR – GAG, Lille, France September 25th 2018, Synaptic function of 3OSTs during AD related tauopathy. A. Maiza (UPEC).

– GDR – GAG, Lille, France September 25th 2018, Heparan sulfates and sulfotransferases: importance in the diagnosis of Alzheimer’s disease. O. Ben Abdelouahab (UPEC). Won Poster Price.

– FENS 7-11Th July 2018 Berlin, Germany. Synaptic function of 3OSTs during AD related tauopathy. A. Maïza (UPEC).

– IMRB Annual Conference, Créteil, France. Synaptic function of 3S-HS and HS3ST2 in physiologic conditions and during Alzheimer disease-related tauopathy. A. Maïza (UPEC).

– Gordon Research Seminar on Fibroblast Growth Factors, Ventura, USA, March 2018. Selective labelling of arginine residues. T. Bui (UoL).

– Gordon Research Conference on Fibroblast Growth Factors, Ventura, USA, March 2018. Selective labelling of arginine residues. T. Bui (UoL).

– FEBS (43th FEBS Congress) Praga, Czech republic, 7-12 July 2018. Differentially expressed plasma microRNAs at early stages of Alzheimer’s disease. Laskowska-Kaszub (NENCKI).

– CONy – 12th World Controversies in Neurology, Warsaw, Poland 22-25 March 2018. Diagnostic prospects of early Alzheimer’s disease based on blood microRNAs. KM. Zoltowska, U. Wojda (NENCKI).

– 14th International Symposium ‘Molecular basis of pathology and therapy in neurological disorders’ Warsaw, Poland October 25-26 2018. Blood-based microRNA diagnostic panel for Alzheimer’s disease: perspective after a decade of research. KM. Zoltowska, K. Laskowska-Kaszub (NENCKI).

– Scientific retreat Radboud Institute of Molecular Life Sciences. Nijmegen, The Netherlands. April 12 & 13, 2018. Development of tools to study 3-O sulfated heparansulfate involved in (patho-)physiological processes. L. Damens (RUMC).

– European Elastin meeting. Nijmegen, The Netherlands. June 14-16, 2018. Development of tools to study the sulfation pattern of heparansulfate involved in elastic fiber biology. L. Damens (RUMC). Won poster prize.

  • Participation to a conference (13: 11 Europe/2 international)

-Invited conference to CReACTIF-23-Club Recherche Alzheimer Compréhension Thérapie – Ile de France, support by association « France Alzheimer » ICM, Paris, France. January 10th, 2019. Roles of Glycosaminoglycans (GAGs) and Heparan Sulphates (HS) in Alzheimer’s Disease. Prof. D. Papy-Garcia (UPEC).

– Half-day research of FST, Créteil, France. June 7th, 2018. Impact of heparan sulfate in memory and in Alzheimer disease. A. Maiza and O. Ben Abdelouahab (UPEC).

– Invited Conference in a new research center called Centro Pfizer – Universidad de Granada – Junta de Andalucía de Genómica e Investigación Oncológica (GENYO), in Granada, SPAIN. June 15th, 2018. Bioinformatics for the discovery of gene survival markers using omic data. Prof. Javier De Las Rivas (FICUS).

-Invited Oral Communication in “Workshop on Integrative Approaches in Neurodegeneration”, 21-23th June 2018, FCUL University of Lisboa, Lisboa, PORTUGAL. June 22th, 2018. Bioinformatics for the discovery of biomarkers: application to the identification of novel gene markers in Alzheimer’s disease. Prof.  Javier De Las Rivas (FICUS).

– Gordon Research Conference on Fibroblast Growth Factors, Ventura, USA, March 2018. FGFs and their sugar partners in flagrante. Prof. DG. Fernig (UoL).

– Allergan Inc., Irvine, USA, March 2018 (NDA and CDA in place2015-2023). Hc/A update and ideas. Prof. DG. Fernig (UoL).

– IBS, Grenoble, France, June 2018. The ins and outs of matrix: molecules, enzymes and viruses. Prof. DG. Fernig (UoL).

– Seminar at the Nencki Institute, Poland. May 15th 2018. Prof. Dulce Papy-Garcia (UPEC).

– Invited lecture, International Congress ‘Psychogeriatry 2018. State of Art’ organized by Polish Psychogeriatric Society, Wroclaw, 30.11-01.12, 2018. Evolving concept of Alzheimer’s disease and development of novel biomarkers. Prof. U. Wojda (NENCKI).

– Invited plenary lecture, 7th Intercollegiate Biotechnological Symposium in Poland, Warsaw, 11-13 May 2018. Alzheimer’s disease: on the way to novel diagnostics and therapies. Prof. U. Wojda (NENCKI).

– Invited lecture, research seminar series for the staff at the Centre of New Technologies of the Warsaw University, Poland March 22nd 2018. Presymptomatic AD: development of novel biomarkers and therapies. Prof. U. Wojda (NENCKI).

– Seminar at the Radboudumc, Nijmegen, the Netherlands. May 28th, 2018. Detection of 3-O sulfated Heparan Sulfate – Development of tools to examine the function of a rare modification. L. Damens (RUMC).

– 26th Symposium on Glycosaminoglycan’s. Sept 13-15th, 2018. Lake Como, Italie. Intracellular 3-O-sulfated heparan sulfates in Alzheimer Disease-related tauopathy. D. Papy-Garcia invited as pleanary speaker (UPEC).

  • Participation to workshop (4)

-Workshop on Opportunities on Health & Technology in H2020. Organized by Research Council – UAB, Spain. October 30th, 2018; Prof. L. Giménez-Llort (UAB).

– Newton Fund Workshop, Hanoi, Vietnam, May 2018. Development of heparin and heparan sulfate glycotherapeutics. Prof. DG. Fernig (UoL).

– Newton Fund Workshop, Hanoi, Vietnam, May 2018. Using sulfotransferases to engineer heparin sulfate function. K. Ramakrishan (UoL).

– Workshop on opportunities of the European Innovation Council in Horizon 2020 organized by the National Contact Point in Poland for Research Programmes of the European Union, session on FETOPEN: “The screening, diagnostic and therapy of Alzheimer’s disease: ArrestAD”, Warsaw, April 12th, 2018. Prof. U. Wojda (NENCKI).

  • Communication campaign (TV, other) (1)

-Invited lecture, Brain Awarness Week organized by the Polish Academy of Sciences,  Przedobjawowe stadium choroby Alzheimera: rozwój metod diagnostyki i terapii” Poznań, March 13th 2018, local TV transmission/recorded www.pan.poznan.pl/tydzien_mozgu/. Prof. U. Wojda (NENCKI).

Advertisements